A 2026 guide to payment, compliance, and margin protection for FQHC CEOs, CFOs, COOs, revenue cycle leaders, compliance officers, and board members.
Federally Qualified Health Centers face the most significant operating environment shift since the Affordable Care Act expansion. Between July 2025 and May 2026, federal Medicaid policy, 340B program architecture, telehealth flexibilities, care management billing codes, and the legal framework governing health center eligibility for federal public benefits have all moved simultaneously. The compounding effect on FQHC margins, payer mix, and compliance exposure is unprecedented.
The seven developments FQHC leaders must understand:
1. The OBBBA Medicaid restructuring. The legislation popularly known as the One Big Beautiful Bill Act — officially titled "An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14" — cuts federal Medicaid funding by an estimated $930 billion over ten years. CBO estimates that the law's health provisions will increase the uninsured population by roughly 10 million to 11.8 million by 2034. NACHC estimates Medicaid work requirements could put coverage at risk for nearly 5.6 million community health center patients over five years.
2. Provider tax safe harbor phase-down. In Medicaid expansion states, the provider tax safe harbor will contract from 6.0% in FY 2028 to 3.5% by FY 2032, reducing state liquidity for supplemental wraparound payments.
3. The end of G0511 and the rise of stacked care management billing. FQHCs with mature clinical workflows can potentially generate $170 to $260+ per highly complex patient per month by combining APCM base codes with new BHI add-on codes (G0568, G0569, G0570) and distinct RPM billing — all available January 1, 2026.
4. The 340B rebate model legal battle. After a December 2025 preliminary injunction and a January 2026 First Circuit refusal to stay it, HHS moved in February 2026 to scrap the existing 340B Rebate Model Pilot. HRSA later issued an RFI on potential rebate models, with comments due April 20, 2026.
5. The Medicaid Managed Care Access Rule. New wait-time enforcement and "secret shopper" audits beginning in 2027–2028 turn scheduling efficiency into a compliance issue exactly as graduate-loan eliminations constrain the clinical workforce pipeline.
6. The PRWORA reinterpretation. A July 2025 federal policy shift classified the Health Center Program as a "Federal public benefit" from which undocumented immigrants are excluded. A federal injunction currently blocks implementation in 21 states and the District of Columbia; FQHCs in non-injunction states face profound operational uncertainty.
7. The $50 billion Rural Health Transformation Program. A notable counterweight to the Medicaid contraction — but the program is administered by CMS rather than HRSA, uses claims-data metrics rather than UDS metrics, and is designed primarily to stabilize rural hospitals. Without active FQHC engagement, ambulatory primary care could see little of this funding.
Three priorities for the next quarter: (1) model cumulative OBBBA financial impact before FY 2028 wraparound disbursement delays begin; (2) capture every available care management code — APCM with BHI/CoCM add-ons and individual RPM codes — that replace the retired G0511; and (3) engage state health departments to ensure ambulatory primary care networks are explicitly written into Rural Health Transformation Program implementation plans.
In This Article
Health centers are not medical practices with a federal grant attached. They operate under a fundamentally different economic model, and many of the pressures they face today cannot be understood without appreciating that distinction.
Payer mix is inverted. In 2024, health centers served roughly 18% uninsured patients and nearly half Medicaid/CHIP patients, with about 90% of patients at or below 200% of the federal poverty level.
Reimbursement is bundled, not fee-for-service. Medicare pays FQHCs through the Prospective Payment System — a bundled per-encounter payment. The 2025 national base PPS rate is $202.65, with a 34.16% adjustment for new patients and wellness visits. Medicaid operates through either state-specific PPS or an alternative payment methodology.
The hybrid funding model creates immense operational complexity. FQHCs must routinely navigate multi-tiered billing — submitting initial claims to managed care plans at negotiated rates, then filing secondary wraparound claims to state Medicaid agencies or MACs to recover the difference between the managed care payment and the statutory PPS rate.
Mission-driven constraints limit strategic flexibility. FQHCs are required by statute to serve all patients regardless of ability to pay, to maintain a Sliding Fee Discount Program, to operate under a community-governed board with a patient majority, and to deliver comprehensive primary care. While Section 330 grant funding helps offset uncompensated care, these grants constitute only roughly 20% of an FQHC's total operating budget.
Operating margins are structurally thin. Capital Link's national benchmarking shows at least one-quarter of health centers report near-zero or negative operating margins in any given year. Recent national data show health center margins have turned negative, with 2024 net margins reported around -2%. Between 2019 and 2023, federal grant funding remained essentially flat while healthcare costs rose more than 25%.
These are the structural challenges that make revenue cycle management at FQHCs fundamentally different from — and harder than — at a typical medical practice.
FQHCs must precisely track the differential between the MCO or MA primary payment and the guaranteed, facility-specific PPS rate. Medicare PPS uses a specific set of G-codes (G0466–G0470) that CMS has not formally updated since 2017. Medicaid PPS rates and rules vary by state. A failure to promptly identify and reconcile shortfalls leads directly to lost revenue once the timely filing windows expire.
FQHCs must credential providers with multiple MCOs, navigate differing prior authorization requirements, and interpret varying EOBs to determine the exact amount paid before generating supplemental wraparound claims. States are legally required to ensure FQHCs receive at least the PPS rate for Medicaid managed care encounters, but the reconciliation process is frequently delayed, inaccurate, or incomplete. While the foundational FQHC encounter rate remains protected under federal law, the OBBBA caps State Directed Payments at 100% of Medicare for expansion states and 110% for non-expansion states — potentially shrinking the supplemental payment pools some states use to elevate FQHC reimbursements above baseline.
As Medicare Advantage enrollment continues to expand — more than half of Medicare beneficiaries are now enrolled in MA plans — FQHCs face heightened risks of systemic underpayment. Claims for MA members must typically be billed using UB-04 claim forms and specific FQHC G-codes. If an MA contract rate falls below the Medicare PPS rate, Medicare is statutorily obligated to pay the difference as a supplemental wraparound payment. Uncaptured supplemental payments are among the largest and most immediately recoverable sources of lost revenue in the FQHC sector.
The post-pandemic Medicaid redetermination process resulted in approximately 25-27 million disenrollments nationwide. NACHC survey data found roughly 23% of health center Medicaid patients lost coverage during the unwinding, with average revenue losses of $595,000 per health center and individual losses reaching $20 million. The OBBBA accelerates this pressure through enhanced FMAP sunset, six-month redeterminations, narrowing of noncitizen eligibility, reductions in provider tax safe harbor, and ACA marketplace disruptions.
FQHC billing requires distinct, heavily customized protocols depending on the payer. Some state Medicaid programs mandate the T1015 encounter code alongside standard CPT codes, while Medicare relies on FQHC-specific G-codes, and commercial payers may demand standard fee-for-service coding. A single health center may simultaneously manage Medicare PPS, Medicaid PPS (or APM), Medicaid managed care across multiple MCOs, Medicare Advantage across multiple plans, commercial insurance, sliding fee scale, Ryan White, and grant-funded encounters — each with different billing rules, code sets, and reconciliation processes.
Maintaining continuous compliance with the HRSA Health Center Program Compliance Manual is resource-intensive. Failure to adhere to governance, needs assessment, credentialing, or sliding-fee documentation requirements can result in progressive administrative action or restrictive conditions on annual grant renewals. The annual UDS submission tracks standardized reporting of patient demographics, diagnoses, services, staffing, and clinical quality measures across all service sites.
While CMS has adopted permanent provisions allowing direct supervision via real-time audio and visual telecommunications, tracking precise origin sites, applying the correct modifiers, and navigating varying state Medicaid parity laws for audio-only versus audio-visual visits remain significant operational hurdles. Billing staff must continuously monitor shifting payer policies to avoid widespread denials of telehealth claims.
FQHC revenue cycle management requires deep, highly specialized familiarity with PPS rules and HRSA compliance standards. Average CFO tenure in the FQHC sector runs only 3 to 5 years. The OBBBA compounds the workforce challenge further upstream — eliminating Federal Direct PLUS loans for graduate students effective July 2026 and capping annual Federal Direct Unsubsidized Stafford loans at $50,000 for professional students. This workforce contraction will collide directly with the Medicaid Managed Care Access Rule's new wait-time enforcement mechanisms, creating compounding compliance exposure.
The 340B Drug Pricing Program has historically subsidized underfunded primary care delivery at FQHCs. However, FQHCs face intensifying margin pressure due to drug manufacturer restrictions on contract pharmacy utilization, shifting CMS outpatient payment policies, state legislative requirements for granular reporting on how 340B savings benefit patients (Idaho, Indiana, Ohio, Rhode Island, Hawaii), and Medicare Drug Price Negotiation under the IRA, which introduces maximum fair prices for highly utilized drugs starting in 2026.
National revenue-cycle data show initial claim denial rates near 12% in recent years. If an FQHC's denial rate is in the low- to mid-teens, it should be treated as a high-priority revenue-cycle issue, with a target of moving toward a low-single-digit preventable denial rate. The fragmentation of healthcare IT systems creates significant data quality issues, as many FQHCs use EHRs that do not seamlessly integrate with their revenue cycle management platforms.
CMS billing changes for 2025 and 2026 represent vital, actionable intelligence for FQHC revenue cycle teams. The intricacies of the new billing framework require precise definition to ensure health centers capture all available revenue streams.
The general care management code that FQHCs used for bundled CCM, RPM, and BHI billing is permanently terminated. Health centers must now report individual CPT and HCPCS care management codes — such as 99490 for Chronic Care Management or 99453 for RPM — at the national non-facility rate. The unbundling allows for more precise reimbursement but significantly increases operational complexity.
FQHCs can now bill for remote patient monitoring using individual CPT codes (99453, 99454, 99457, 99458) rather than bundling under G0511. This creates a discrete revenue stream that most health centers have not yet implemented.
CMS introduced Advanced Primary Care Management, bundling CCM, Transitional Care Management, and Principal Care Management under HCPCS codes G0556, G0557, and G0558. Centers must choose between APCM and reporting individual care management codes — the two cannot be used for the same patient in the same month.
New codes G0568, G0569, and G0570 allow FQHCs to bill APCM to add complementary Behavioral Health Integration and psychiatric Collaborative Care Model services for the same patient in the same month. Combined with APCM base codes and layered RPM, this creates a stacking opportunity capable of generating $170–$260+ per complex patient per month for health centers with the requisite clinical and technological infrastructure.
G0512, G0071, and G0017 unbundled. FQHCs must report individual codes previously bundled. The bundled code G0071 is no longer reportable; FQHCs should report G2010, G2250, and 98016 individually. Telecommunication code G0017 has been removed entirely. Preventive vaccine billing: CMS finalized a rule requiring FQHCs to bill for preventive vaccines and their administration at the actual time of service, improving cash flow. Same-day dental and medical visits can now both be billed on the same day when dental services are inextricably linked to medical services.
| CY 2026 Conversion Factor | Rate / Adjustment | Strategic Implication |
|---|---|---|
| Qualifying APM Participant (QP) | $33.5675 (+3.77%) | Significant financial incentive to participate in Advanced APMs |
| Non-Qualifying APM Participant | $33.4009 (+3.26%) | Baseline increase for traditional fee-for-service providers |
| OBBBA Statutory Increase | 2.5% (temporary) | One-year baseline boost for CY 2026, temporarily buffering inflation |
The legislation, popularly known as the One Big Beautiful Bill Act, is the single most consequential piece of legislation affecting FQHCs since the ACA. During Senate amendment, the Senate Minority Leader invoked the Byrd Rule to strip the short title; the law is formally titled "An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14."
Enhanced FMAP sunset (January 1, 2026). OBBBA eliminates the temporary ARPA incentive for states that newly adopt Medicaid expansion. The permanent ACA 90% federal match remains in place. The five-percentage-point FMAP boost from ARPA for states that expanded after March 2021 is also eliminated.
Work requirements (effective January 2027). Non-disabled adults aged 19 to 64 must complete at least 80 hours per month of employment, job training, or community service to maintain Medicaid eligibility. NACHC projects that up to 5.6 million FQHC patients could lose coverage. Research from Arkansas's prior experiment found that reporting requirements themselves were a major driver of coverage loss, with no measurable increase in employment.
Six-month redeterminations (effective December 31, 2026). States must redetermine eligibility for the ACA expansion population every six months rather than annually — doubling the administrative burden on both state agencies and FQHCs assisting patients with renewals.
Noncitizen Medicaid narrowing (effective October 1, 2026). Section 71109 narrows the categories of noncitizens eligible for full Medicaid services. Humanitarian entrants — refugees, asylees, and parolees — will lose Medicaid eligibility. Only Lawful Permanent Residents (5+ years), certain Cuban or Haitian entrants, and Compact of Free Association migrants remain eligible.
Mandatory cost-sharing (effective October 1, 2028). States must impose cost-sharing of up to $35 per service on adults with incomes between 100% and 138% of FPL for expansion. Primary care, mental health, substance use disorder services, and all services provided by FQHCs, CCBHCs, and RHCs are explicitly exempted — a critical operational advantage added during congressional deliberations.
| Provision | Mechanism | Effective | Impact on FQHCs |
|---|---|---|---|
| Provider Tax Safe Harbor | Phased 6.0% → 3.5% | FY 2028–2032 | Reduces state liquidity for wraparound payments |
| State Directed Payments | Capped at 100% Medicare (expansion) | Enactment | Constrains MCO capacity to inflate encounter rates |
| Cost-Sharing (100–138% FPL) | Up to $35/service | October 1, 2028 | FQHCs explicitly exempt |
| Noncitizen Eligibility | Eliminates refugee/asylee/parolee coverage | October 1, 2026 | Shifts insured encounters to sliding fee scale |
| Work Requirements | 80 hours/month | January 2027 | Up to 5.6M FQHC patients at risk (NACHC) |
| Six-Month Redeterminations | Expansion population | December 31, 2026 | Doubles renewal administrative burden |
| Fiscal Year | Provider Tax Safe Harbor Limit |
|---|---|
| FY 2025 – FY 2027 | 6.0% (frozen at enactment) |
| FY 2028 | 5.5% |
| FY 2029 | 5.0% |
| FY 2030 | 4.5% |
| FY 2031 | 4.0% |
| FY 2032+ | 3.5% |
The mechanism reduces the non-federal share of revenue that states use to draw down federal matching funds. Health centers rely heavily on supplemental wraparound payments to recover the differential between managed care capitation rates and the statutory PPS encounter rate. As the 3.5% ceiling constrains state liquidity, Medicaid agencies are likely to institute more aggressive utilization reviews, delay reconciliation disbursements, and structurally restrict the distribution of wraparound pools. Revenue cycle directors should audit and recover outstanding wraparound receivables immediately, insulating cash reserves before the initial FY 2028 provider tax phase-down triggers state-level payment delays.
Marketplace changes will make subsidized coverage harder to maintain. Pre-enrollment verification effectively ends automatic renewal of premium tax credits for passive re-enrollees, and the enhanced premium tax credits were not extended; without extension, CBO estimates the uninsured population will rise by about 4.2 million by 2034. Many of these individuals could rely on FQHCs as their primary or sole source of care.
The OBBBA eliminates Federal Direct PLUS loans (Grad PLUS) for graduate students effective July 2026 and imposes new annual borrowing caps on unsubsidized Direct loans ($50,000 for professional students). These changes could reduce the number of physicians, nurse practitioners, physician assistants, and behavioral health providers entering the workforce — a particular concern for FQHCs that depend on National Health Service Corps loan repayment programs to recruit clinicians to underserved areas.
As a notable counterweight to broader Medicaid contraction, the OBBBA establishes a $50 billion Rural Health Transformation Program (RHTP) under Section 71401, appropriating $10 billion per year from FY 2026 through FY 2030. However, the program's administrative structure introduces competitive friction that determines whether FQHCs see any of this money.
Administration. CMS — not HRSA — administers the fund. CMS evaluates transformation based on claims data, technological interoperability, and hospital-centric delivery system stabilization, rather than the traditional UDS metrics used by HRSA. FQHCs accustomed to HRSA-style narratives will need to translate their value proposition into CMS-aligned language emphasizing claims data, care transitions, interoperability, and measurable cost reduction.
State application process. States' RHTP applications were due November 5, 2025, and CMS announced approved awards by December 31, 2025.
Strategic context. As KFF has noted, the RHTP is temporary and front-loaded, while nearly two-thirds of OBBBA Medicaid spending reductions are scheduled to take effect after FY 2030. Because state transformation plans were already submitted, FQHCs cannot passively rely on Section 330 status to secure allocations. Without active FQHC engagement during state implementation, a substantial share of discretionary funding could flow to rural hospital priorities rather than ambulatory primary care infrastructure. This is among the most important strategic positioning challenges of the next 18 months for any rural-serving FQHC.
| Tranche | Allocation | Methodology |
|---|---|---|
| Tranche 1 (Statutory) | 50% of total funds | Distributed equally among all approved states |
| Tranche 2 (Discretionary) | 50% of total funds | Allocated by CMS based on rural population, rural facility proportion, hospital risk factors |
HRSA's Health Center Program Compliance Manual remains the core compliance reference, with a technical revision dated November 20, 2025. The manual defines a progressive action cycle for non-compliance with strict 90-, 60-, 30-, and 120-day intervals for corrective action. The 120-day implementation phase applies when a federally approved corrective action plan requires additional time for complex programmatic and organizational changes. HRSA requires patient board members, as a group, to reasonably represent the individuals served by the health center. Non-patient board members may be selected for relevant expertise in community affairs, finance, legal affairs, business, or health care.
HRSA has paused implementation of UDS+, the Uniform Data System modernization effort for de-identified patient-level reporting using HL7 FHIR-based interoperability standards. Health centers should continue to focus on strengthening data capture, validation, mapping, and vendor workflows while awaiting further guidance from HRSA. For calendar year 2025 UDS reporting, the submission deadline was February 15, 2026, with final corrected submissions due March 31, 2026.
Direct supervision via telecommunications (permanent). CMS permanently adopted a definition of direct supervision that allows supervising practitioners to provide supervision through real-time audio and visual interactive telecommunications. This definition excludes audio-only supervision; video capability is required.
Non-behavioral health telehealth extended through December 31, 2027. FQHCs report these visits using HCPCS code G2025, which covers services furnished via audio-only communication technology. The CY 2026 payment rate for G2025 is $97.53.
In-person requirement for mental health telehealth delayed until at least January 1, 2028.
Audio-only mental health telehealth is permanently authorized.
The judicial and administrative volatility surrounding the 340B Drug Pricing Program requires careful strategic forecasting from every FQHC pharmacy leader and CFO. The legal landscape has shifted significantly in just the past five months.
For an FQHC operating on a structurally thin 1% to 2% margin, the requirement to float the substantial acquisition cost of specialty therapeutics until a rebate is adjudicated poses a significant cash-flow risk. CFOs should model the working capital impact of a rebate scenario now, not when it is announced.
Federal courts protect contract pharmacy networks. On March 3, 2026, the U.S. District Court for the District of Columbia overturned HRSA's burdensome child site registration requirements, ruling the agency lacked statutory authority.
Fifth Circuit upholds state contract pharmacy protections. On February 9, 2026, the Fifth Circuit upheld a Louisiana statute protecting 340B contract pharmacy access, rejecting manufacturer preemption and Takings Clause arguments.
IRA drug price negotiation compressing 340B spreads. Maximum fair prices for selected drugs take effect in 2026, narrowing the differential between 340B acquisition costs and reimbursement.
State transparency laws expanding in Idaho, Indiana, Ohio, Rhode Island, and Hawaii, requiring increasingly granular reporting on how 340B savings benefit patients.
State contract pharmacy protections expanding. More than 28 states have introduced or enacted legislation. Health centers should engage regional primary care associations to support state-level anti-discrimination statutes addressing manufacturer restrictions.
The operational burden imposed by the Medicaid Managed Care Access Rule introduces a compliance vector that deserves leadership attention. Finalized to ensure adequate network capacity, the rule requires states to publish comprehensive Medicaid fee schedules online by July 2026 and compare those rates to Medicare benchmarks. New State Directed Payment caps (100% / 110% of Medicare) take effect.
The enforcement teeth: To guarantee managed care plans meet wait-time standards for primary care, mental health, and obstetrics, states must deploy annual independent "secret shopper" surveys beginning in 2027 and 2028. For community health centers facing clinical staffing shortages — exacerbated by the elimination of OBBBA Grad PLUS — failing a secret-shopper wait-time audit could trigger network adequacy penalties from the MCO. The rule also requires states to establish Beneficiary Advisory Councils by July 9, 2025.
Operations directors should overhaul front-desk scheduling algorithms and deploy automated wait-list management software to ensure that third-party secret shopper audits do not result in network exclusion or capitation penalties.
In July 2025, HHS rescinded a 1998 interpretation, formally classifying the Health Center Program and Head Start as "Federal public benefits" from which undocumented immigrants are statutorily excluded.
The judicial response has produced a bifurcated national landscape. On September 10, 2025, a federal district court issued a preliminary injunction blocking implementation across twenty plaintiff states and the District of Columbia. For health centers operating within the protective jurisdiction of this injunction, operations continue under historic norms. However, for FQHCs located in non-plaintiff states, the operational exposure is significant.
A critical legal clarification. PRWORA restricts access to federal benefits. States retain authority to use non-federal money to provide benefits to nonqualified immigrants. The federal administration acknowledged that the July 2025 notices of interpretation are non-binding guidance and do not create a legal obligation that overrides a state's ability to issue clarifying legislation reaffirming continued access to state-funded programs. FQHC leadership teams in non-plaintiff states should retain specialized legal counsel to draft provisional registration scripts that balance federal compliance with state-level protections. This is separate from and additional to the OBBBA's noncitizen Medicaid eligibility restrictions.
Community Health Center Fund at $4.6 billion for FY 2026. NACHC described this as the largest increase to the CHCF in a decade. Against the backdrop of projected Medicaid coverage losses and an estimated $930 billion reduction in federal Medicaid funding, the $4.6 billion CHCF stabilization serves as a cushion rather than a comprehensive replacement for lost encounter revenue.
MAHA Elevate — A $100 million CMS Innovation Center program funding three-year cooperative agreements focused on evidence-based functional or lifestyle medicine interventions for Original Medicare beneficiaries. FQHCs explicitly eligible. Letter of Intent due April 10, 2026; final application May 15, 2026.
RCORP-Impact — Rural Communities Opioid Response Program Impact grants offering up to $750,000 annually over a four-year project period.
Rural Residency Planning and Development grants for workforce pipeline development.
Pediatric Mental Health Care Access Program awards.
While the regulatory environment has tightened, newly finalized policies, coding updates, and emerging funding streams present substantial opportunities. Health centers must actively pursue structural revenue optimization — cost-cutting alone will not sustain operations through the changes ahead.
Why it matters: Uncaptured MA supplemental payments can represent tens to hundreds of thousands of dollars annually. Many FQHCs have never systematically submitted these claims.
What it requires: Documented MA contract rates on file with the MAC, EMR configuration to flag eligible encounters, automated workflows to generate secondary claims within timely filing limits.
Timeline: Immediate.
Why it matters: Given OBBBA's State Directed Payment caps and the impending provider tax phase-down beginning in FY 2028, ensuring baseline wraparound capture becomes a non-negotiable cash-flow priority.
Target: Wrap recovery rate of 95% or higher with monthly reconciliation and 30-to-90-day resolution.
Timeline: Immediate.
Why it matters: The new billing landscape creates a stacking opportunity capable of generating $170 to $260+ per patient per month.
Timeline: APCM and BHI add-ons available now. RPM is a multi-quarter implementation.
Why it matters: Denial rates of 12–15% far exceed the HFMA benchmark of 5%. Each prevented denial saves on rework costs and revenue delays.
What it requires: Automated claim scrubbing configured for FQHC billing logic, denial tracking by category and root cause, front-end eligibility verification. Revele's AR and denial management solutions are purpose-built for this work.
Timeline: Immediate.
Why it matters: Uncaptured charges represent pure margin loss. Same-day behavioral health, dental, and group visits may each qualify for separate PPS payment.
What it requires: Independent coding audits, automated charge capture cross-referencing, and provider documentation education.
Timeline: Immediate.
Why it matters: Telehealth preserves visit volumes and reduces no-shows, protecting PPS encounter revenue at the G2025 rate ($97.53 in 2026). It also directly supports compliance with the Medicaid Managed Care Access Rule's wait-time standards.
Timeline: Available now through at least 2027 for non-behavioral health; permanent for mental health.
Why it matters: 340B remains a critical margin contributor, but IRA drug price negotiation is compressing spreads, the threat of rebate model disruption persists, and state transparency laws are expanding.
What it requires: Rigorous patient eligibility verification, compliant split-billing systems, sophisticated TPA oversight, strategic formulary management, and scenario planning for a possible shift to rebates.
Why it matters: APM participants receive higher Medicare conversion factor increases ($33.5675 / +3.77% vs. $33.4009 / +3.26%). Shared savings and quality bonuses exist outside the traditional PPS rate.
What it requires: Attribution modeling, population health tools, quality reporting, and governance capacity for financial risk. MSSP one-sided risk is limited to five years (effective 2027). ACO REACH participants must prepare for the 2027 LEAD Model transition.
Why it matters: The $50 billion RHTP represents the largest new federal investment in rural health infrastructure since the ACA. However, without active FQHC engagement at the state level, the funding will flow almost entirely to inpatient facilities.
What it requires: Direct engagement with state health departments, governors' offices, and state hospital associations. Health centers should submit data on rural access gaps, trends in uncompensated care, chronic disease burden, and interoperability capabilities — all translated into CMS-aligned language.
Timeline: State applications were due November 5, 2025; CMS announced approved awards by December 31, 2025. Engage in state-level advocacy now.
Why it matters: With Section 330 funding only accounting for ~20% of revenue, diversifying federal grant funding reduces single-source dependency.
Application deadline for MAHA Elevate: May 15, 2026.
Why it matters: Ambient documentation pilots report meaningful reductions in provider documentation time — up to 30 minutes per provider. RPA for real-time eligibility checks prevents denials at the point of service.
Timeline: Emerging. Start with a controlled pilot measuring baseline documentation time.
Why it matters: Missing income verification violates HRSA rules and produces downstream bad debt. With Medicaid churn accelerating under the OBBBA, front-end accuracy becomes even more consequential.
What it requires: Automated eligibility verification, insurance discovery software, rigorous SFDP training, and automated wait-list management.
Initiate a forensic audit of wraparound workflows. Model the OBBBA's cumulative revenue impact across all provisions, not just work requirements in isolation. Quantify the gap between current sliding fee scale collections and the true cost of delivering care to newly uninsured patients. Finalize EMR crosswalk to individual care management codes. Build RPM and APCM stacking revenue projections. Model 340B cash flow under a rebate scenario.
Integrate the HRSA Compliance Manual's 90/60/30/120-day progressive action timeline into all internal audit protocols. Revise governance bylaws to leverage the new board member's expertise and flexibility. Verify billing system configuration for all 2026 code changes. Confirm 340B audit readiness. Retain specialized legal counsel for PRWORA injunction monitoring. Begin building HL7, USCDI, and FHIR data capabilities for the eventual UDS+ transition.
Pilot ambient clinical documentation in high-volume departments. Overhaul front-end registration and scheduling — high turnover, OBBBA-driven Medicaid churn, and managed-care wait-time audits combined make this the highest-leverage operational investment. Deploy automated wait-list management. Develop Medicaid redetermination outreach protocols. Consider designating an MA billing specialist.
Deploy RPA for real-time eligibility checks. Audit telehealth platforms for direct supervision compliance and EMR mapping. Implement automated claim scrubbing with FQHC-specific logic. Configure EHR for APCM, BHI, CoCM, and RPM code capture. Build interoperability capabilities that can be documented for CMS RHTP applications.
Institute monthly dashboard review of:
| Action Item | Primary Owner | Target Timeframe | Strategic Impact |
|---|---|---|---|
| Finalize G0511 transition | CFO / RCM Director | Complete | Prevents cessation of care management revenue |
| Activate APCM and BHI codes (G0568–G0570) | CMO / IT Director | Q1–Q2 2026 | Captures net-new behavioral health revenue |
| Execute wraparound capture audit | CFO | Immediate | Recovers leaked revenue before FY 2028 phase-down |
| Model comprehensive OBBBA financial impact | CFO / COO | Q2 2026 | Quantifies exposure across all provisions |
| Submit MAHA Elevate application | CEO / Grants Director | By May 15, 2026 | $100M CMS Innovation Center program |
| Finalize UDS data validation | Compliance Officer | Prior to Feb 15, 2026 | Maintains HRSA compliance and grant standing |
| Assess ambient AI ROI | COO / CMO | Next 6 months | Reduces burnout, improves coding accuracy |
| Review HRSA Compliance Manual | Compliance Officer | Immediate | Prevents OSV findings |
| Evaluate PRWORA legal exposure | CEO / Legal Counsel | Ongoing | Mitigates uncompensated care and compliance risk |
| Engage state RHTP implementation | CEO / COO | Immediate | Positions FQHC for share of $50B rural investment |
| Stress-test 340B contract pharmacy network | CFO / Pharmacy Director | Q2 2026 | Prepares for potential rebate model revival |
| Renegotiate managed care contracts | CFO / COO | Q2–Q3 2026 | Secures adequate rates before enrollment changes |
| Deploy wait-list / scheduling automation | COO / IT Director | Q3 2026 | Prepares for secret shopper audits |
| Launch RPM business case | CMO / CFO | Next 6 months | Creates per-patient monthly recurring revenue |
| Assess workforce pipeline exposure | COO / HR Director | Q3 2026 | Plans for Grad PLUS elimination impact |
| Build Medicaid redetermination outreach | COO / Patient Services | Q3–Q4 2026 | Prepares for six-month redetermination cycles |
| Begin UDS+ readiness (HL7/USCDI/FHIR) | IT / Compliance | Q3–Q4 2026 | Prepares infrastructure for mandatory transition |
The legislation popularly known as the One Big Beautiful Bill Act has no official short title. During Senate amendment debate, the Senate Minority Leader invoked the Byrd Rule to strip the short title, arguing that the bill's name did not directly pertain to budgetary matters. The law is formally titled "An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14."
CBO projects 11.8 million people will lose Medicaid coverage over ten years. NACHC projects that up to 5.6 million of those losses will come directly from FQHC patient populations, primarily through work requirements (effective January 2027), six-month redeterminations (effective December 31, 2026), and noncitizen eligibility narrowing (effective October 1, 2026).
Yes. Effective October 1, 2028, states must impose cost-sharing of up to $35 per service on Medicaid expansion adults with incomes between 100% and 138% of FPL. Primary care, mental health, substance use disorder services, and services provided by FQHCs, CCBHCs, and RHCs are explicitly exempted.
The bundled care management code G0511 sunsets on October 1, 2025. FQHCs must now report individual CPT and HCPCS care management codes — such as 99490 for Chronic Care Management or 99453 for Remote Patient Monitoring — at the national non-facility rate. FQHCs may alternatively bill APCM codes G0556, G0557, or G0558, but cannot combine APCM with individual care management codes in the same month for the same patient.
Effective January 1, 2026, FQHCs billing APCM can also bill G0568, G0569, and G0570 to add Behavioral Health Integration and psychiatric Collaborative Care Model services for the same patient in the same month. These services are paid at the national non-facility rate and represent net-new revenue for health centers with integrated behavioral health capacity.
A federal court in Maine vacated the 340B Rebate Model Pilot Program on February 5, 2026, following the U.S. District Court's issuance of a preliminary injunction on December 29, 2025, which the First Circuit declined to stay on January 7, 2026. Manufacturers must continue providing upfront 340B discounts. However, HRSA issued a Request for Information on rebate model alternatives, which closed on April 20, 2026, and received over 5,500 comments.
The RHTP appropriates $10 billion annually from FY 2026 through FY 2030. CMS — not HRSA — administers the fund. Half of the $50 billion is distributed equally among approved states; the other half is allocated by CMS based on rural population, proportion of rural health facilities, and hospital risk factors. State applications were due November 5, 2025, with approved awards announced by December 31, 2025.
MAHA Elevate is a $100 million program administered by the CMS Innovation Center. It funds three-year cooperative agreements focused on evidence-based, whole-person functional or lifestyle medicine interventions to address chronic disease epidemics among Original Medicare beneficiaries. FQHCs are explicitly eligible applicants. The application deadline is May 15, 2026.
In July 2025, HHS rescinded a 1998 interpretation and classified the Health Center Program as a "Federal public benefit" from which undocumented immigrants are statutorily excluded. On September 10, 2025, a federal district court issued a preliminary injunction blocking enforcement in twenty plaintiff states and the District of Columbia. FQHCs in non-injunction states face operational uncertainty. PRWORA only restricts access to federal benefits; states retain authority to use non-federal money to provide benefits to nonqualified immigrants.
Monthly metrics should include wrap recovery rate (target ≥95%), initial claim denial rate (target <5% per HFMA benchmark), time to wrap resolution (30–90 days), payer mix trend (Medicaid, uninsured, sliding fee percentages), uncompensated care cost per visit, and wait times by service line (primary care, mental health, obstetrics) for Medicaid Managed Care Access Rule compliance.
The FQHC operating environment is not simply getting harder — it is restructuring. The payer mix that sustained many health centers through the ACA expansion era is contracting under the combined weight of Medicaid work requirements, six-month redetermination cycles, noncitizen eligibility restrictions, enhanced FMAP sunsets, provider tax safe harbor phase-downs reaching 3.5% by FY 2032, State Directed Payment caps, and ACA marketplace disruptions.
The billing framework that consolidated care management under a single code is gone, replaced by a more granular system that rewards health centers with the capacity to track, document, and bill for every qualifying service. The 340B program faces an entrenched federal commitment to potentially restructuring its architecture, which could affect FQHCs' working capital. The Medicaid Managed Care Access Rule turns wait times into a compliance liability at exactly the moment when graduate loan eliminations are constraining the clinician pipeline. A federal reinterpretation of immigration law has introduced compliance uncertainty, necessitating state-by-state legal monitoring.
The $50 billion Rural Health Transformation Program and the $4.6 billion Community Health Center Fund provide a cushion — but the RHTP is temporary, state-mediated, CMS-administered rather than HRSA-administered, and not guaranteed to flow to FQHCs unless health centers actively engage state plan implementation. The CHCF increase is nominal against the scale of Medicaid contraction. Federal grant funding cannot offset the combined effects of coverage loss, inflation, and rising operational costs.
The health centers that will navigate this successfully are those that treat revenue cycle management as a strategic function rather than an administrative afterthought.
That means investing in front-end processes, closing billing gaps, capturing every dollar of supplemental payment, building the clinical and data infrastructure to participate in care management, RPM, and value-based care programs, deploying AI-enabled tools to reduce administrative burden, and engaging in the state and federal policy processes that will determine how much of the available funding reaches community health centers.
The margin for error has narrowed. The margin for action has not — but it will.
Revele works with FQHCs, CHCs, RHCs, and physician organizations on the specific revenue cycle, coding, and operational work this analysis demands — wraparound payment capture, denial reduction, APCM/BHI/RPM workflow build-out, 340B scenario modeling, and HRSA compliance support.
Revele has recently unlocked its acclaimed RISE Program to all medical practices and community health centers.
Disclaimer: The content published by Revele is provided for informational and educational purposes only and does not constitute legal, medical, financial, or tax advice. Healthcare laws, payer policies, credentialing requirements, and compliance standards are highly complex and subject to frequent change. While Revele makes every effort to ensure the information shared is accurate and current at the time of publication, we make no representations or warranties, express or implied, regarding the completeness or accuracy of this information.
Readers and users must consult with qualified professionals, regulatory authorities, or independent legal and financial advisors for advice specific to their individual circumstances before making any strategic, clinical, or operational decisions.
This analysis reflects confirmed regulatory, legislative, and policy developments through May 2026. Sources include An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law 119-21), CMS final rules and guidance, HRSA program announcements, the Congressional Budget Office, the Government Accountability Office, NACHC, the Federal Register, KFF, Capital Link, the American Medical Association, Feldesman Tucker Leifer Fidell LLP, and relevant federal court decisions.